Intercept Appoints Andrew Saik as Chief Financial Officer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Marvell shares jump after giving Google warrants amid custom chip deal
Piper Sandler Positive on Intercept Pharmaceuticals (ICPT) Latest Hires
June 9, 2021 11:01 AM EDTPiper Sandler analyst Yasmeen Rahimi reiterated an Overweight rating and $82.00 price target on Intercept Pharmaceuticals (NASDAQ: ICPT) after the company's latest hire - M. Michelle Berrey, M.D., M.P.H., as President of Research & Development and Chief Medical Officer. This follows... More
